Guest Bloggers
-
Louisa Benton
Executive Director
-
Steven P. Roose, M.D
Professor of Clinical Psychiatry
-
Huda Akil, Ph.D
DTF Chair
Novel Depression Treatment in the News,
February 15, 2019
A new antidepressant is expected to soon be approved by the Food and Drug Administration.
The New York Times reported yesterday that an advisory panel at the agency has voted in favor of recommending approval of the new drug, the nasal spray Esketamine, to treat severely depressed patients.
Click here to read the full article…